Objective. To evaluate the quality of patients care, a set of indicators of the standards of cancer care were defined.
Introduction
Evidence-based guidelines are increasingly regarded as essential in cancer care. Indicators are measurement tools that can be used for monitoring all aspects of the health care process or outcome and to implement evidence-based medicine [1, 2] . Numerous organizations have developed quality measures for surgical and oncology care [3] : recently, it has been suggested that indicators may be useful to assess adherence of hospital with individual aspects of care and to improve evidence-based actions in local networks [3 -5] . However, the use of indicators for population-based assessment of the quality in large network is still rare.
In Tuscany a population-based regional network to coordinate and to improve the quality of cancer care for the entire region, the Istituto Toscano Tumori (ITT, www.ittumori.it), has been set up since 2003. The first aim of the ITT was to produce shared cancer clinical recommendations for the management of the most frequent types of solid tumors as well as indicators of the standards of cancer care. Information was obtained on the entire population of Tuscany, involving tracing all cancer patients resident in the Region, whether cared for by public or private providers, based on the regional cancer registry where all the information of cancer cases in residents of the region was collected for the year 2004.
The main objective was to show the feasibility of evaluating quality of care at population level using cancer registry data. Another objective was to assess the level of adherence to the ITT cancer care recommendations, through quality indicators for colorectal cancer, lung cancer and breast cancer.
To validate the 2004 results an ad hoc population-based survey was used for year 2006.
Methods

Data sources
The study included all the resident population of the Tuscany Region (3585000 inhabitants in 2004). The regional health system is organized on 12 local health authorities that refer to three macro areas (Area Vasta). A university hospital is the cancer reference center within each Area Vasta. In this study participants were considered eligible if they had a new diagnosis of female breast or colorectal or lung cancer and were registered as incident cases in the Tuscan Cancer Registry. The cancer registry collects all cancers incident during the years of registry activity. In our study, exclusion criteria included prevalent tumors, multiple tumors and cases cared for in other regions. Results were analyzed at three sub-regional areas.
The Tuscany Cancer Registry has been active in about one-third of the Tuscany region since 1985. The first year of extension to all the regional population was 2004. Incident cases were identified through hospital discharge notes, pathology reports, death certificates, oncological archives: once the case is defined, each source of information contributes with specific data, including, for example, tumor histology, stage at diagnosis, type of treatment and follow-up [6] . Not all sources can be available for all cases, thus, quality of data in a cancer registry is evaluated by the percentage of microscopically verified cases, by the percentage of cases known from death certificate only, and by the mortality/incidence ratio. The Tuscany Cancer Registry showed a good quality of data, with a high percentage of microscopically verified cases and very low percentage of cases known from the death certificate only (80 and 1%, respectively) [7] .
In total 2591 breast, 2381 lung and 2419 colorectal cancer incident cases were included in this study (tab 1). For each patient all the electronic available health information from the Tuscany region information system was collected: pathology reports, hospital discharge notes including day hospital and computerized records of outpatient. Data were checked for quality and completeness, if needed, in cooperation with the local hospital departments using local electronic or clinical health records, particularly for therapeutic information.
Validation set
For 2006, a sample of eligible patients who received surgery was selected from the hospital discharge notes of all public and private hospitals using the same criteria used during 2004. Prevalent cancer cases were excluded by merging with the cancer registry. Clinical charts and pathology reports from all the regional providers were collected. In order to avoid over-representing patients from larger clinical centers, the sampling fraction for larger hospitals .150 cancer cases was the 20%, whereas in smaller centers all cases were investigated.
In 
The list of indicators
The ITT had published recommendations on diagnosis and treatment of solid tumors [8] in 2005 based on an expert panel of health professionals in a consensus process based on their experience and on scientific literature. The preliminary set of indicators was compared with the list of indicators available from scientific literature, other organizations [9, 10] , guidelines [11 -14] , extensive systematic literature reviews, and review of articles published in the Medline database from 2000 to 2006. Web sites of professional societies and organizations that monitor quality of medical care were accessed to identify currently available clinical practice guidelines and quality measures. The indicators encompassed the diagnostic and therapeutic phases of breast, colorectal and lung cancer care, and were reviewed by a multidisciplinary panel of members belonging to the regional network previously involved in developing the ITT recommendations. Indicators were identified regarding events on diagnosis, surgical therapy, adjuvant and neoadjuvant therapy. Structural indicators were not included. A core set of 32 quality indicators regarding diagnosis, treatment and follow-up care was selected: 10 were specific for lung, 7 for colon, 11 for rectum and 14 for breast cancer. The most important literature references for each indicator are presented in Tables 2-4 .
Analysis
To verify the possibility to measure agreement between clinical practice and recommendations, the selected indicators were retrospectively evaluated on data from the Cancer Registry in 2004.
Data were analyzed for the whole region and for macro areas for patients younger and older than 75 years separately, as older patients are less likely to receive standard treatment than younger ones [15] . Only results regarding patients younger than 75 years and for the whole region were presented. Furthermore, in this paper data are presented by residence of patients and not by providers of diagnosis or treatment.
The proportion of patients who fulfilled each of the indicators was determined. The average percent compliance was calculated with 95% confidence intervals for each of the indicators. For each item, the numerator was the number of patients who were compliant with each of the indicators and the denominator was the total number of eligible patients.
Results
The most relevant characteristics of the patients are listed in Table 1 High adherence to recommendations was generally showed for indicators related both to diagnosis and treatment. However, some critical aspects were found: proportion of breast cancer patients with adjuvant chemotherapy performed within 1 month after surgery was ,40% and proportion of patients who underwent reconstructive surgery after mastectomy was 27% ( Table 2) .
The most important and interesting finding was the use of intraoperative diagnosis which was clearly preferred in the surgical departments of an area of the ITT network.
Furthermore, a non-homogeneous use of new approaches was found, like sentinel lymph node and c-erb-2 testing for breast cancer. University hospitals were the only ones performing these techniques in 2004. Moreover, regarding sentinel lymph node evaluation, a difference among geographical areas was also shown, with a larger use of this technique only in one among the three areas.
The use of chemotherapy in women with breast cancer was higher in patients with lymph node involvement ( Table 2 ) than in women without lymph node metastasis, according to literature [16] .
Colorectal cancer
Adherence with the indicators ranged from 62 to 85% among the 1683 colon cancer patients and from 20 to 89% among the 736 rectal cancer patients diagnosed in 2004. In rectal cancer care, an high proportion of patients with pathological cancer stage III received adjuvant chemotherapy (89%) while for patients with pathological cancer stage II the proportion was lower (61%) ( Table 3 ).
An adequate number of lymph nodes examined (12 or more lymph nodes) in at least 70% of colon cancer patients (Table 3) was found, according to recommendation.
Lung cancer
Adherence to each indicator of lung cancer care ranged from 2 to 95% among the 2381 lung cancer patients diagnosed in 2004. The indicators related to therapeutic phase showed that the proportion of patients who underwent surgery, including all stages disease, was 21%, according to data from the Surveillance, Epidemiology and End Results, where the percentage of lung cancer patients who had resectable disease in 2002 was 23% [17] . In the diagnostic phase, the use of mediastinoscopy was very low in all areas of the network (2%). This indicator, however, was analyzed for all lung cancer patients, whereas it could be useful to stratify data by clinical stage. The proportion of patients who underwent neoadjuvant chemotherapy in 2004 was lower (15%) than the proportion of patients who underwent adjuvant radiotherapy (38%) ( Table 4) therapy within 1 month prior to death showed that in 24% of patients chemotherapy was performed. The low perioperative mortality (2.8%) suggested a good quality of surgery.
Data from 2006
Results 
Discussion
The main result of this study is that a population-based evaluation of the quality of cancer care using cancer registry data and major computerized information systems is feasible, also in large areas. The use of the 2004 Cancer Registry data was satisfactory for the estimate of the whole target population. Population-based data from a registry are useful to evaluate adherence of indicators to guideline, also analyzing the geographical differences among regional areas.
Priority was given to citizen perspective. The local health authority must offer a high-quality level for each indicator independent on the kind of provider. There are many providers available to the citizen resident in a local authority area (local versus the university hospital, for example) but the main responsibility of the local health authority is to provide a good standard of quality in any setting of care the patient may choose.
Indicators were selected evaluating the feasibility of measurement through the informative regional data set, the possibility to perform analysis in a short period of time and the volume of providers of interest. We reported regional average, without referent threshold; in the literature, however, quality standards were reported [14, 18 -21] , particularly in the evaluation of screen-detected breast cancers [13] .
In our experience, the use of cancer registry has been fundamental for monitoring the care of cancer patients in a community setting [22] . Population-based cancer registries provide a large number of patients and include all persons in the community. They provide the date of incidence and the living status of the patient, essential information for the evaluation of the clinical pathway of each cancer case [23 -25] . A limitation in the use of data collected by the cancer registry is that some information, particularly regarding treatment, may not be completely recorded or may be missing. However, for 2004 all incident cases collected from cancer registry were considered and the completeness of the cancer registry in Tuscany is high [26] .
Data quality of registry was confirmed by quality indicators which are similar to the average of the Italian registry network.
Analysis on data set from 2006, based on data extracted from the same population used for registry, generally confirmed the results obtained with cancer registry data in 2004 or showed an increased adherence to recommendation. The data from 2006 were from hospital discharge notes integrated with the pathology report and clinical charts, with very good data completeness.
Our results can be compared with the literature that describes the quality of cancer care. In 2004, the result in the Tuscany regional system confirmed a good homogeneity among areas and globally the estimate of the selected indicators showed a good performance.
Patients with breast, lung and rectum cancer receive .60% of recommended care, and patients with colon cancer receive .75% of recommended care in 2004; adherence to several quality measures reached 90%.
Globally, our data showed that cancer care in our region is as good as that reported in the literature. The results of the National Initiative for Cancer Care quality showed that patients with breast cancer receive 86% of recommended care and patients with colorectal cancer receive 78% of recommended care [27] , whereas other studies found that patients with colorectal cancer receive 86% of recommended care [28] . In each indicator, for some of these selected measures rates were similar to data from the literature, as, for example, for the proportion of patients with stage III rectal cancer who received adjuvant therapy, whereas in stage II our data found a lower proportion of patients than in other recent studies [28] . The proportion of patients whose colorectal cancer was detected by screening was 16.5% in a recent analysis, according to our data [29] .
A low adherence was observed for some quality measures, particularly regarding use of adjuvant therapy. For some of these measures, as sentinel lymph node evaluation in breast cancer, there was variability across the three regional areas and the adoption of these techniques was higher in university hospitals.
Our analysis found that data from cancer registry linked with electronic health records can be useful to evaluate quality of cancer care. Further work, however, is needed to develop specific quality measures about structural data, like hospital volume or access to care. Furthermore, indicators will need to be continually updated and revised with the improvement of scientific knowledge and of the information system. funzione di sorveglianza e monitoraggio della rete oncologica regionale: gli strumenti di rilevazione e il sistema di indicatori per la valutazione degli enti e della innovazione tecnologica").
